Sarepta Therapeutics | SRPT - 销售和管理费用

金融业

USD

USD 3.18B

现金及等价物

USD 464.45M

USD 109.46M

USD 2.31B

USD 499.16M

USD 1.04B

USD 358.43M

USD -252.2M

1.37K

EPS每股收益

USD 3.16

股本和储备

USD 1.51B

USD 621.34M

债务利息支出

USD 20.84M

USD 8.74M

USD 838.16M

USD 1.41B

USD 330.96M

USD 372.37M

USD 358.43M

普通股股本

USD 105.57M

27.27

USD 343.17M

USD 730.8M

销售和管理费用

USD 54.03M

USD 1B

贸易债权人

USD 70.38M

应收帐款人

USD 547.91M

	销售和管理费用	更改		日
Acadia Pharmaceuticals	USD 160.79M		14.06M	2026-03
Agios Pharmaceuticals	USD 38.46M		4.51M	2026-03
Alnylam Pharmaceuticals	USD 282.51M		2.55M	2026-03
Amgen	USD 1.58B		354M	2026-03
BioCryst Pharmaceuticals	USD 95.78M		12.77M	2025-12
Biogen	USD 554.3M		128.2M	2026-03
BioMarin Pharmaceutical	USD 258.28M		63.92M	2026-03
Capricor Therapeutics	USD 1.92M		446.47K	2025-12
Daiichi Sankyo	JPY 228.23B		39.15B	2025-12
Eli Lilly	USD 2.93B		198M	2026-03
Esperion Therapeutics	USD 39.42M		456K	2025-12
Gilead Sciences	USD 1.45B		326M	2026-03
Incyte	USD 328.1M		62.31M	2026-03
Insmed	USD 247.26M		34.78M	2026-03
Ionis Pharmaceuticals	USD 151M		21M	2026-03
Moderna	USD 173M		135M	2026-03
Nektar Therapeutics	USD 10.17M		10.17M	2025-12
Neurocrine Biosciences	USD 318.5M		16.7M	2026-03
Novavax	USD 25.53M		1.34M	2025-12
Pfizer	USD 2.92B		1.16B	2026-03
PTC Therapeutics	USD 73.89M		13.31M	2026-03
Regeneron Pharmaceuticals	USD 647.7M		127.3M	2026-03
Roche Holding	CHF 7.28B		3.99B	2025-12
Sangamo BioSciences	USD 9.64M		1.83M	2024-06
Sanofi	EUR 2.33B		419M	2026-03
Sarepta Therapeutics	USD 54.03M		51.35M	2026-03
Tectonic Therapeutic	USD 3.44M		1.52M	2025-12
Ultragenyx Pharmaceutical	USD 88M		1000K	2026-03
Vertex Pharmaceuticals	USD 493.7M		6.7M	2026-03